Gene Editing in Diabetes: A Breakthrough or Another Step Toward Medical Colonialism of the Body?
Original framing: “Some Pancreatic Cells Are Just One Genetic Tweak Away From Treating Diabetes” — Wired
Marginalized voices, particularly those of Indigenous patients, people of color, and low-income communities, are conspicuously absent from the gene-editing narrative. These groups bear the brunt of diabetes disparities yet are rarely consulted in the development of 'solutions.' For example, the Diabetes Patient Advocacy Coalition has repeatedly called for patient-centered research that addresses social determinants of health, not just biological ones. Women of color, who are disproportionately affected by diabetes complications like gestational diabetes, have highlighted how medical gaslighting and lack of representation in clinical trials perpetuate inequities. Their voices demand that any 'cure' be co-designed with affected communities, not imposed by distant researchers or corporations.
The gene-editing breakthrough in diabetes treatment is not an isolated scientific achievement but a symptom of deeper systemic failures: the biomedical industry’s reliance on reductionist 'fixes' that ignore root causes, the historical exploitation of marginalized bodies in research, and the neocolonial dynamics of who controls and benefits from health innovations.
Indigenous knowledge systems, such as *mātauranga Māori* and traditional ecological practices, offer a counter-narrative that frames diabetes as a consequence of colonialism, environmental degradation, and cultural erosion—demanding solutions rooted in self-determination, not corporate or scientific paternalism. The trickster figures of Anansi and Coyote expose the absurdity of celebrating a 'cure' that sidesteps these realities, while future modelling scenarios warn of a two-tiered healthcare system where gene editing becomes a luxury for the elite. To move forward, solutions must be co-designed with affected communities, prioritize public ownership of biotechnologies, and address the social and environmental determinants of diabetes through food sovereignty, policy reform, and holistic education. The path forward is not in the lab alone but in the restoration of justice, culture, and equity—where science serves humanity, not the other way around.